A detailed history of Continental Investors Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Continental Investors Services, Inc. holds 2,063 shares of ABBV stock, worth $356,940. This represents 0.89% of its overall portfolio holdings.

Number of Shares
2,063
Previous 2,033 1.48%
Holding current value
$356,940
Previous $348,000 16.95%
% of portfolio
0.89%
Previous 0.8%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$163.84 - $199.33 $4,915 - $5,979
30 Added 1.48%
2,063 $407,000
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $4,488 - $5,242
-29 Reduced 1.41%
2,033 $348,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $11,666 - $13,293
73 Added 3.67%
2,062 $375,000
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $262,905 - $304,351
-1,968 Reduced 49.73%
1,989 $296,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $267,537 - $332,933
2,019 Added 104.18%
3,957 $533,000
Q1 2023

Apr 27, 2023

SELL
$144.61 - $166.54 $2,024 - $2,331
-14 Reduced 0.72%
1,938 $308,000
Q4 2022

Feb 28, 2023

BUY
$138.31 - $165.87 $8,713 - $10,449
63 Added 3.34%
1,952 $315,000
Q3 2022

Dec 15, 2022

SELL
$134.21 - $153.93 $16 Million - $18.3 Million
-119,000 Reduced 98.44%
1,889 $254,000
Q3 2022

Nov 22, 2022

BUY
$134.21 - $153.93 $16 Million - $18.3 Million
119,001 Added 6303.02%
120,889 $17.3 Million
Q2 2022

Aug 17, 2022

BUY
$137.62 - $174.96 $6,468 - $8,223
47 Added 2.55%
1,888 $289,000
Q1 2022

Jun 13, 2022

SELL
$131.98 - $163.75 $5,411 - $6,713
-41 Reduced 2.18%
1,841 $249,000
Q4 2021

Jun 13, 2022

BUY
$107.43 - $135.93 $202,183 - $255,820
1,882 New
1,882 $305,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Continental Investors Services, Inc. Portfolio

Follow Continental Investors Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental Investors Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Continental Investors Services, Inc. with notifications on news.